RUNX2 and bladder transitional cell carcinoma: However, the biological roles of LAMA2 and RUNX2 and their specific molecular mechanism in BLCA remain unclear, which inspire us to further elucidate the potential underlying mechanism through molecular experiments and clinical trials.